Ocular Gene Therapy


Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.


  • Gene replacement
  • DNA Nanoparticle
  • RNA Interference
  • Ex vivo for Retinal Pigmentosa

Related Conference of Ocular Gene Therapy

December 15-16, 2022

3rd World Congress on Ophthalmology & Optometry

London, UK
February 02-03, 2023

6th International Eye and Vision Congress

Barcelona, Spain
February 20-21, 2023

4th International Conference on Ear Nose & Throat

Singapore City, Singapore
April 20-21, 2023

8th International Conference on Eye and Vision

Paris, France
May 17-18, 2023

23rd Global Ophthalmologists Annual Meeting

Prague, Czech Republic
May 24-25, 2023

3rd International Conference on Optics & Photonics

Montreal, Canada
May 31-01, 2023

9th Global Ophthalmology Meeting

Rome, Italy
July 26-27, 2023

17th International Conference on Hepatology

Singapore City, Singapore
July 31-01, 2023

37th European Ophthalmology Congress

Vancouver, Canada
August 28-29, 2023

22nd Asia Pacific Ophthalmologists Annual Meeting

Tokyo, Japan
September 18-19, 2023

33rd International Congress on Vision Science and Eye

Rome, Italy
October 09-10, 2023

4th International Conference on Optometry

Prague, Czech Republic
November 01-02, 2023

19th International Conference on Metabolomics

Rome, Italy

Ocular Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in